Ed LeCluyse, PhD, and Paul Gallant, BA, of LifeNet Health provide an inside look at a novel all-human hepatic triculture system developed by LifeNet Health LifeSciences. Find out how this new system addresses the need for a convenient and human-relevant long-term hepatic culture. Key topics include:

• An overview of how the new all-human hepatic triculture mimics native liver tissue architecture and key hepatocellular functions over several weeks
• How hepatocytes are pre-qualified to reduce variability for a broad range of pharmacological and toxicological applications
• The flexibility of this system and how it allows researchers to choose from a selection of hepatocyte lots, enabling a broad population diversity
• The advantages of this system - which offers the simplicity of a 2D model, with the robust levels of data typical of 3D models - compared to existing models